Format
Sort by

Send to:

Choose Destination

Results: 5

1.

Monitoring the Dynamics of T Cell Clonal Diversity Using Recombinant Peptide:MHC Technology.

Blanchfield JL, Shorter SK, Evavold BD.

Front Immunol. 2013 Jul 3;4:170. doi: 10.3389/fimmu.2013.00170. eCollection 2013.

2.

Cytokine-neuroantigen fusion proteins as a new class of tolerogenic, therapeutic vaccines for treatment of inflammatory demyelinating disease in rodent models of multiple sclerosis.

Mannie MD, Blanchfield JL, Islam SM, Abbott DJ.

Front Immunol. 2012 Aug 20;3:255. doi: 10.3389/fimmu.2012.00255. eCollection 2012.

3.
5.

Experimental autoimmune encephalomyelitis in Lewis rats: IFN-beta acts as a tolerogenic adjuvant for induction of neuroantigen-dependent tolerance.

Mannie MD, Abbott DJ, Blanchfield JL.

J Immunol. 2009 May 1;182(9):5331-41. doi: 10.4049/jimmunol.0803756.

Format
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk